{ "docId": "019dd923-5de0-76bd-a164-b86a30509f49", "docSlug": "6e629024b6ef9521", "documentTitle": "Medical Affairs Outlook Report 2025", "authorId": "ZS", "authorName": "ZS", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "strategy_consulting", "sourceTypeLabel": "Strategy consulting", "presentationDate": null, "orientation": "portrait", "aspectRatio": 0.773, "pageNumber": 10, "pageCount": 23, "prevPage": 9, "nextPage": 11, "slideType": "executive_summary", "function": "summarize", "density": "overcrowded", "nDataPoints": 6, "notes": "The slide is a text-heavy summary page from a white paper, likely part of a larger report on medical affairs trends.", "elementsJson": [ "paragraph", "bullet_list" ], "metadataConfidence": 0.9, "imagePath": null, "slideHref": "/slides/019dd923-5de0-76bd-a164-b86a30509f49/10", "deckHref": "/decks/019dd923-5de0-76bd-a164-b86a30509f49", "deckJsonHref": "/decks/019dd923-5de0-76bd-a164-b86a30509f49.json", "deckAnchorHref": "/decks/019dd923-5de0-76bd-a164-b86a30509f49#slide-10", "components": [ { "bbox": null, "kind": "callout", "text": "Investing in various aspects of medical affairs will only be effective if MSLs are well prepared to engage and deliver relevant insights.", "attrs": null, "subkind": null, "toolName": "Visual emphasis", "toolSlug": "visual-emphasis", "confidence": null, "componentId": "019dd951-edaa-73b9-9026-14d7f4dd785d", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.085, "w": 0.65, "x": 0.214, "y": 0.499 }, "kind": "list", "text": "Gen AI: The current adoption of generative AI for optimizing operations and enhancing stakeholder engagement is moderate. However, nearly 90% of respondents indicated their organizations plan to invest in generative AI for data analysis and insights generation in the future. Additionally, gen AI will be used for scientific literature review and summarization, as well as content creation and personalization.", "attrs": null, "subkind": "bullet", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "94c72f25-d1e6-4ed1-9139-a24e4d32d63b", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.085, "w": 0.65, "x": 0.214, "y": 0.399 }, "kind": "list", "text": "CRM systems: By advancing their CRM capabilities, the industry is moving toward better data capture to drive personalization. Veeva and Salesforce are identified as the most commonly used CRM systems among medical affairs teams. Approximately 80% of respondents said their organizations are concentrating on platform integration, scalability and advanced analytics to enhance their CRM capabilities.", "attrs": null, "subkind": "bullet", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "af7b8de3-0513-40fd-b30c-0d1386aeba74", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.085, "w": 0.65, "x": 0.214, "y": 0.299 }, "kind": "list", "text": "Technology: A major focus for investment is technology that improves the collection and processing of customer insights. Nearly three-fourths of internal respondents indicated their organizations are prioritizing investments in insights collection and analytics systems. Over 60% of MSLs said AI and analytics, digital engagement platforms and CRM systems are receiving the next levels of investment.", "attrs": null, "subkind": "bullet", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "c2325c73-84df-4776-8be2-419d08002ebf", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.285, "w": 0.65, "x": 0.214, "y": 0.599 }, "kind": "paragraph", "text": "Investing in various aspects of medical affairs will only be effective if MSLs are well prepared to engage and deliver relevant insights. Without their active involvement and expertise, these investments may not translate into improved customer engagement and satisfaction. In fact, 26% of medical affairs professionals highlight the importance of redefining the role of future MSLs as a key enabler of the next generation of medical affairs. By focusing on improving digital proficiency, scientific expertise and involving MSLs throughout the product life cycle, organizations can ensure their investments lead to meaningful outcomes. Therefore, upskilling and training MSLs is critical to unlocking their full potential and enhancing the impact of their engagements. The majority of KOLs consider delivering personalized and valued engagement, along with strong scientific and clinical knowledge, as essential skills for MSLs. More than a quarter of these leaders believe that medical affairs organizations should prioritize training MSLs in these areas to enhance their capabilities and effectiveness. This focus aligns with the strategic initiatives organizations are undertaking to develop MSLs, ensuring they are well equipped to meet the evolving demands of the field.", "attrs": null, "subkind": "paragraph", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "03341428-19e8-4991-9be3-ff3bbaf23e69", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.115, "w": 0.65, "x": 0.214, "y": 0.168 }, "kind": "paragraph", "text": "Pharmaceutical organizations are strategically investing in advanced technologies to enhance the precision, speed and impact of medical affairs activities. Modern CRMs are being leveraged to guide field strategy, prioritize scientific discussions and align medical plans with broader objectives. At the same time, generative AI is streamlining tasks and reducing manual workloads to accelerate decision-making. Gen AI tools are being deployed with specific use cases in mind, enabling medical affairs teams to turn insights into action and deliver scientific value more effectively across the organization.", "attrs": null, "subkind": "paragraph", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "a39f4f56-4667-45af-aacc-fdd9f9136e94", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.048, "w": 0.65, "x": 0.214, "y": 0.103 }, "kind": "paragraph", "text": "This progression is essential for maximizing the impact of both personal and nonpersonal engagement channels, ensuring that medical affairs can deliver value at scale and adapt to the evolving preferences of stakeholders.", "attrs": null, "subkind": "paragraph", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "ddde9f15-3728-46d6-8803-98d0ae60003e", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.015, "w": 0.095, "x": 0.839, "y": 0.038 }, "kind": "title", "text": "WHITE PAPER", "attrs": null, "subkind": "headline", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "40792206-d046-4044-bed4-f08c36bf7d16", "frameworkName": null, "frameworkSlug": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [], "loops": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }